Enochian Biosciences, Inc. (ENOB)
| Market Cap | 51.81M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -108.60M |
| Shares Out | 55.71M |
| EPS (ttm) | -2.06 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 23,452 |
| Open | 0.950 |
| Previous Close | 0.930 |
| Day's Range | 0.920 - 0.980 |
| 52-Week Range | 0.900 - 8.880 |
| Beta | 1.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 3, 2023 |
About ENOB
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-... [Read more]
Financial Performance
Financial StatementsNews
Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher
LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc. (the “Company”) announces that Dr. Anahid Jewett, a renowned cancer researcher in the field of immunotherapy f...
Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements
LOS ANGELES, March 13, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc. (the Company) announced that it has achieved full compliance with NASDAQ filing requirements. The Annual Repor...
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022
LOS ANGELES, Feb. 23, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- On February 16, 2023, Enochian BioSciences Inc. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nas...
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022
LOS ANGELES, Nov. 30, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- On November 23, 2022, Enochian BioSciences Inc. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nas...
Enochian BioSciences Forges Ahead With Focused Approach, Promising Future
LOS ANGELES, Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB)—Enochian BioSciences (the Company) recently announced significant progress toward re-prioritizing its focus on curing some of the world's ...
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K
LOS ANGELES, Oct. 21, 2022 (GLOBE NEWSWIRE) -- On October 17, 2022, Enochian BioSciences, Inc. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that...
Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform
Initial, Pre-Clinical Animal Study Results Show Potential To Effectively Treat Pancreatic Cancer Initial, Pre-Clinical Animal Study Results Show Potential To Effectively Treat Pancreatic Cancer
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Enochian BioSciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2022 - (NASDAQ: ENOB)
NEW YORK , Sept. 28, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Enochian BioSciences, Inc..
ENOB FINAL DEADLINE TODAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
New York, New York--(Newsfile Corp. - September 26, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB) be...
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming September 26, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of inve...
Bronstein, Gewirtz & Grossman, LLC Reminds Enochian Biosciences Inc. (ENOB) Investors of Class Action and Encourages Investors to Contact the Firm
New York, New York--(Newsfile Corp. - September 23, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Enochian Biosciences Inc.
MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 23, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...
ENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022
NEW YORK , Sept. 23, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Enochian BioSciences, Inc. (NASDAQ: ENOB).
Enochian Class Action: Levi & Korsinsky Reminds Enochian BioSciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 26, 2022 - ENOB
New York, New York--(Newsfile Corp. - September 22, 2022) - Levi & Korsinsky, LLP notifies investors in Enochian BioSciences, Inc. ("Enochian" or the "Company") (NASDAQ: ENOB) of a class action securi...
MONDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 22, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...
ENOB LAWSUIT ALERT: Levi & Korsinsky Notifies Enochian BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK , Sept. 22, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Enochian BioSciences, Inc. ("Enochian" or the "Company") (NASDAQ: ENOB) of a class action securities lawsuit.
ENOB Investors Have Opportunity to Lead Enochian Biosciences, Inc. Securities Fraud Lawsuit
BENSALEM, Pa. , Sept. 20, 2022 /PRNewswire/ -- Law Offices of Howard G.
ENOB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 26, 2022 in the Class Action Filed on Behalf of Enochian BioSciences, Inc. Shareholders
NEW YORK , Sept. 20, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Enochian BioSciences, Inc. (NASDAQ: ENOB) alleging that...
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Enochian Investors of a Lead Plaintiff Deadline of September 26, 2022
NEW YORK , Sept. 19, 2022 /PRNewswire/ -- Attention Enochian BioSciences, Inc. ("Enochian") (NASDAQ: ENOB) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commen...
ENOB FINAL DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
NEW YORK , Sept. 17, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB) between January 17, ...
SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline - ENOB
New York, New York--(Newsfile Corp. - September 17, 2022) - Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. ("Enochian" or the "Company") (NASDAQ: ...
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 15, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 14, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...
ENOB LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Enochian BioSciences, Inc.
New York, New York--(Newsfile Corp. - September 13, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Enochian BioS...